Laporan Laba Rugi (TTM)
Laporan Laba Rugi HLB Life Science Co., Ltd. - Equity Right menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102,427 | 91,797 | 70,598 | 62,917 | 57,296 | 53,494 | 58,848 | 61,067 | 87,628 | 99,591 | 114,798 | 120,360 | 101,918 | 97,990 | 73,870 | 59,918 | 64,157 | 102,240 | 104,634 | 108,925 |
| Change (%) | -10.38 | -23.09 | -10.88 | -8.93 | -6.63 | 10.01 | 3.77 | 43.49 | 13.65 | 15.27 | 4.84 | -15.32 | -3.85 | -24.62 | -18.89 | 7.08 | 59.36 | 2.34 | 4.10 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 94,563 | 89,630 | 68,632 | 61,155 | 55,754 | 59,155 | 62,197 | 66,120 | 93,629 | 102,813 | 118,192 | 123,109 | 104,857 | 98,915 | 77,070 | 63,393 | 67,882 | 104,809 | 107,629 | 111,223 |
| Change (%) | -5.22 | -23.43 | -10.89 | -8.83 | 6.10 | 5.14 | 6.31 | 41.60 | 9.81 | 14.96 | 4.16 | -14.83 | -5.67 | -22.08 | -17.75 | 7.08 | 54.40 | 2.69 | 3.34 | |
| % of Revenue | 92.32 | 97.64 | 97.22 | 97.20 | 97.31 | 110.58 | 105.69 | 108.27 | 106.85 | 103.24 | 102.96 | 102.28 | 102.88 | 100.94 | 104.33 | 105.80 | 105.81 | 102.51 | 102.86 | 102.11 |
| Gross Operating Profit | 7,863 | 2,167 | 1,965 | 1,762 | 1,542 | -5,661 | -3,350 | -5,053 | -6,001 | -3,222 | -3,393 | -2,750 | -2,939 | -925 | -3,200 | -3,475 | -3,724 | -2,569 | -2,996 | -2,298 |
| Change (%) | -72.45 | -9.28 | -10.35 | -12.49 | -467.10 | -40.83 | 50.86 | 18.77 | -46.32 | 5.32 | -18.97 | 6.91 | -68.53 | 245.98 | 8.57 | 7.18 | -31.03 | 16.62 | -23.29 | |
| % of Revenue | 7.68 | 2.36 | 2.78 | 2.80 | 2.69 | -10.58 | -5.69 | -8.27 | -6.85 | -3.23 | -2.96 | -2.28 | -2.88 | -0.94 | -4.33 | -5.80 | -5.81 | -2.51 | -2.86 | -2.11 |
| SG&A | 9,142 | 7,637 | 7,534 | 7,936 | 7,882 | 7,954 | 8,208 | 8,319 | 10,098 | 10,665 | 11,973 | 13,291 | 13,463 | 16,104 | 16,167 | 12,066 | 11,745 | 11,103 | 11,079 | 15,665 |
| Change (%) | -16.46 | -1.36 | 5.35 | -0.68 | 0.91 | 3.20 | 1.35 | 21.38 | 5.62 | 12.26 | 11.01 | 1.29 | 19.62 | 0.39 | -25.36 | -2.66 | -5.46 | -0.22 | 41.39 | |
| % of Revenue | 8.93 | 8.32 | 10.67 | 12.61 | 13.76 | 14.87 | 13.95 | 13.62 | 11.52 | 10.71 | 10.43 | 11.04 | 13.21 | 16.43 | 21.89 | 20.14 | 18.31 | 10.86 | 10.59 | 14.38 |
| R&D | 1,124 | 1,431 | 1,526 | 2,704 | 3,087 | 3,846 | 4,316 | 3,759 | 4,008 | 4,349 | 4,274 | 4,679 | 4,670 | 5,454 | 5,749 | 5,732 | 5,768 | 5,177 | 5,246 | 5,580 |
| Change (%) | 27.33 | 6.66 | 77.16 | 14.17 | 24.57 | 12.23 | -12.93 | 6.63 | 8.52 | -1.73 | 9.48 | -0.18 | 16.79 | 5.40 | -0.29 | 0.62 | -10.24 | 1.32 | 6.38 | |
| % of Revenue | 1.10 | 1.56 | 2.16 | 4.30 | 5.39 | 7.19 | 7.33 | 6.15 | 4.57 | 4.37 | 3.72 | 3.89 | 4.58 | 5.57 | 7.78 | 9.57 | 8.99 | 5.06 | 5.01 | 5.12 |
| OpEx | 106,036 | 99,815 | 78,569 | 72,810 | 67,729 | 71,823 | 75,571 | 79,038 | 108,785 | 119,541 | 136,550 | 143,956 | 126,332 | 123,483 | 101,938 | 83,592 | 87,496 | 123,278 | 125,948 | 134,702 |
| Change (%) | -5.87 | -21.29 | -7.33 | -6.98 | 6.05 | 5.22 | 4.59 | 37.64 | 9.89 | 14.23 | 5.42 | -12.24 | -2.25 | -17.45 | -18.00 | 4.67 | 40.90 | 2.17 | 6.95 | |
| % of Revenue | 103.52 | 108.73 | 111.29 | 115.72 | 118.21 | 134.26 | 128.42 | 129.43 | 124.14 | 120.03 | 118.95 | 119.60 | 123.95 | 126.02 | 138.00 | 139.51 | 136.38 | 120.58 | 120.37 | 123.67 |
| Operating Income | -3,610 | -8,018 | -7,971 | -9,893 | -10,433 | -18,329 | -16,723 | -17,970 | -21,158 | -19,950 | -21,751 | -23,596 | -24,414 | -25,493 | -28,068 | -23,674 | -23,339 | -21,038 | -21,314 | -25,777 |
| Change (%) | 122.13 | -0.58 | 24.10 | 5.47 | 75.68 | -8.76 | 7.46 | 17.74 | -5.71 | 9.03 | 8.48 | 3.47 | 4.42 | 10.10 | -15.66 | -1.41 | -9.86 | 1.31 | 20.94 | |
| % of Revenue | -3.52 | -8.73 | -11.29 | -15.72 | -18.21 | -34.26 | -28.42 | -29.43 | -24.14 | -20.03 | -18.95 | -19.60 | -23.95 | -26.02 | -38.00 | -39.51 | -36.38 | -20.58 | -20.37 | -23.67 |
| Interest Expense | -9,321 | -2,109 | -1,944 | -1,768 | -1,606 | -1,256 | -858 | -422 | -71 | -9,870 | -14,700 | -19,919 | -25,654 | -21,650 | -22,611 | -22,296 | -21,026 | -16,819 | -13,642 | -11,725 |
| Change (%) | -77.38 | -7.84 | -9.05 | -9.16 | -21.78 | -31.69 | -50.83 | -83.19 | 13,818.24 | 48.93 | 35.51 | 28.79 | -15.61 | 4.44 | -1.39 | -5.70 | -20.01 | -18.89 | -14.05 | |
| % of Revenue | -9.10 | -2.30 | -2.75 | -2.81 | -2.80 | -2.35 | -1.46 | -0.69 | -0.08 | -9.91 | -12.80 | -16.55 | -25.17 | -22.09 | -30.61 | -37.21 | -32.77 | -16.45 | -13.04 | -10.76 |
| Net Income | 3,809 | -55,797 | -45,888 | -63,998 | -28,397 | -49,152 | -44,045 | -20,834 | -56,700 | -54,277 | -30,251 | -46,626 | -74,410 | -5,983 | 125,455 | -9,205 | 71,046 | 6,138 | -196,098 | -77,700 |
| Change (%) | -1,564.84 | -17.76 | 39.47 | -55.63 | 73.09 | -10.39 | -52.70 | 172.15 | -4.27 | -44.27 | 54.13 | 59.59 | -91.96 | -2,196.71 | -107.34 | -871.87 | -91.36 | -3,294.88 | -60.38 | |
| % of Revenue | 3.72 | -60.78 | -65.00 | -101.72 | -49.56 | -91.88 | -74.85 | -34.12 | -64.71 | -54.50 | -26.35 | -38.74 | -73.01 | -6.11 | 169.83 | -15.36 | 110.74 | 6.00 | -187.41 | -71.33 |
Source: Capital IQ
